Research Leaders / KOL Map

Heart Failure: Research Leaders and Landscape

The most active researchers, institutions, and subtopics in Heart Failure, from recent PubMed records. Public authorship only, every figure verifiable by PMID.

Analyzed 600 recent PubMed papers (2021-2026) matching "heart failure SGLT2 inhibitor preserved ejection fraction". Source: NLM PubMed. Generated July 2026.

Top research leaders (by recent publication volume)

#ResearcherAffiliationPapers
1Vaduganathan MuthiahBrigham and Women's Hospital67
2Butler JavedBaylor Scott and White Research Institute53
3Zannad FaiezUniversité de Lorraine39
4Packer MiltonBaylor University Medical Center35
5Petersson MagnusBioPharmaceuticals R&D35
6Filippatos GerasimosNational and Kapodistrian University of Athens School of M34
7Ferreira João PedroUniversité de Lorraine33
8Langkilde Anna MariaBioPharmaceuticals R&D31
9Verma SubodhSt Michael's Hospital24
10Brueckmann MartinaBoehringer Ingelheim International GmbH23
11Ponikowski PiotrWroclaw Medical University21
12Vardeny OrlyUniversity of Minnesota20
13Martinez FelipeUniversidad Nacional de Córdoba18
14Böhm MichaelUniversitätsklinikum des Saarlandes18
15Kondo ToruUniversity of Glasgow14
16Miao Zi MichaelBrigham and Women's Hospital13
17Lindholm DanielBioPharmaceuticals R&D13
18Senni MichelePapa Giovanni XXIII Hospital12

Ranked by recent publication volume; names not yet disambiguated and not citation-weighted. The full brief adds ORCID disambiguation, citation weighting, and clinical-trial investigator data.

Leading institutions

University of Glasgow (74), Brigham and Women's Hospital (68), Northwestern University Feinberg School of Medicine (52), Duke University Medical Center (40), Yale School of Medicine (40), National and Kapodistrian University of Athens School of M (29), BioPharmaceuticals R&D (28), Boehringer Ingelheim International GmbH (28), Université de Lorraine (27), Erasmus Medical Center (27)

Active subtopics

Heart Failure (497), Stroke Volume (424), Sodium-Glucose Transporter 2 Inhibitors (380), Benzhydryl Compounds (244), Glucosides (242), Diabetes Mellitus, Type 2 (151), Ventricular Function, Left (147), Treatment Outcome (86), Glucose (51)

Top journals

European journal of heart failure (38), JACC. Heart failure (24), Cardiovascular diabetology (21), ESC heart failure (21), Circulation (21), Journal of the American College of Cardiology (19)

Representative recent papers

Combination cardiometabolic therapy in type 2 diabetes: optimizing SGLT2 inhibitor and GLP‑1 receptor agonist use. (2026) · PMID 42470502

Impact of SGLT2 inhibitors in cardiac amyloidosis: A systematic review and meta-analysis. (2026) · PMID 42437182

[Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i): A Therapeutic Revolution Beyond Diabetes. New Indications in Non-Diabetic Chr (2026) · PMID 42423061

Cardiovascular Drug Access in Australia and New Zealand: New PBS and PHARMAC Listings, 2023-2025. (2026) · PMID 42409691

Gaps in Guideline-Directed Medical Therapy for Heart Failure: A Cross-Sectional Study in an Underserved Population. (2026) · PMID 42359428

Want the full cited brief?

A full Heart Failure brief adds citation weighting, name disambiguation, clinical-trial investigators, and a cited PDF, scoped to your exact molecule, competitor set, or region.

Try the live tool Contact us